BioClinica to Address Shifting Priorities of Clinical Trial Professionals At Upcoming Industry Events

NEWTOWN, Pa., Jan. 23, 2014 /PRNewswire/ -- BioClinica®, Inc., a global provider of clinical trial management solutions, today announced that its Imaging, Cardiac Safety, and eClinical Solutions experts will speak at, and participate in, several key industry events in North America, Asia, and Europe in the first quarter of 2014. The Company also announced that it will host the BioClinica European User Conference in Cologne, Germany exclusively for customers in response to growing demand for EDC, CTMS, IRT, and Optimizer clinical supplies planning solutions. Participation at these events reinforces BioClinica's commitment to advancing clinical trials and supporting the development of novel therapeutics. At each conference, there will be an opportunity to join BioClinica authorities in conversation about scientific findings and latest industry trends related to medical imaging and cardiac safety as well as to see the full suite of eClinical technologies and solutions in live demonstrations.

(Logo:  http://photos.prnewswire.com/prnh/20130403/PH87647LOGO )

Outsourcing in Clinical Trials West Coast 6th Annual Conference
January 28-29
San Francisco, CA

BioClinica is a sponsor and exhibitor at this event where California's San Francisco Bay Area pharmaceutical, biotech and medical device community will come together to discuss clinical outsourcing challenges. The conference will feature many distinguished speakers and provide a platform to network and come away with best practices for implementing outsourcing strategies. BioClinica representatives will be available to discuss comprehensive Imaging and Cardiac Safety services and best-in-class eClinical Solutions in exhibit booth #29.

Asian Regional Drug Development Summit 2014 (ARDDS)
February 18-20
Shanghai, China

BioClinica is a Thought Leadership sponsor for ARDDS 2014, the leading Asian Clinical Trials conference ARDDS. Attendees will get up-to-date, comprehensive information to aid them in addressing region-specific regulatory, operational and logistical challenges of drug development. Hundreds of clinical professionals will convene on topics including regulatory harmonization and development strategies, clinical data management, and partnerships. Jeff Heilbraun, VP of Strategic Development at BioClinica will give a talk entitled "Blood pressure as a CV safety endpoint: implications for Asian and global drug development" that will focus on the current scientific and regulatory trends in blood pressure monitoring for clinical trials.

Third Annual Data Management in Clinical Trials 2014
February 19-20
Vienna, Austria

Jonathan Andrus, SCDM 2014 Chair and BioClinica Senior Vice President of Operations heads a distinguished panel of speakers for this event geared especially for clinical data management professionals. Jonathan will present the opening address to data quality and management professionals, entitled 'The Ever-changing Data Management Landscape' in which he will cover trending topics surrounding standards, guidance, and best practices.  

IOF-ISCD Skeletal Health 2014
Current Concepts in Osteoporosis Assessment and Management
February 20-22
Orlando, FL

The International Osteoporosis Foundation (IOF) and the International Society for Clinical Densitometry (ISCD) Skeletal Health meeting covers the most current, clinically-relevant concepts on the assessment and management of Osteoporosis. The meeting will bring together a diverse group of clinical professionals, physicians, and Key Opinion Leaders (KOLs) from medical disciplines and specialties involved in the diagnosis and treatment of Osteoporosis and related diseases. BioClinica's Senior Vice President of Medical Affairs Colin G. Miller, PhD will be attending the meeting and a study focused on DXA scanner cross-calibration utilizing BioClinica's Spine and Total Body Composition imaging phantoms has been selected for an oral presentation.   

BioClinica European User Conference
February 26
Cologne, Germany

BioClinica will hold its 2014 European User Conference in Cologne, Germany. Current customers will share ideas and experiences, voice their technology needs, and learn how to use BioClinica's latest product features. The conference includes product demonstrations, case studies, and customer-led presentations by Johnson & Johnson, Nestlé, Grünenthal, Sanofi, Biosense Webster, TauRx, and Cerbomed, and more. BioClinica Technology Partner, NNIT, will present a session on SharePoint implementation, systems integration and validation. The exclusive invitation-only event will be held at the Microsoft Executive Briefing Center in Cologne, a fitting location as BioClinica is an elite member of Microsoft's Partner Network. 

Partnerships in Clinical Trials 2014
March 30-April 2
Las Vegas, NV

The 23rd Annual Partnerships in Clinical Trials is North America's largest conference serving the global clinical trials, operations and outsourcing community. The comprehensive event will include interactive learning opportunities covering the entire clinical value chain, including clinical outsourcing, research and operations. BioClinica representatives will be in exhibit booth #1016 to demonstrate innovative eClinical Solutions and discuss comprehensive Imaging and Cardiac Safety services for advancing clinical trials.

To request a meeting with BioClinica during any of these events, email [email protected].

About BioClinica, Inc.

BioClinica, Inc. is a leading global provider of integrated clinical trial management technologies including eClinical solutions for electronic data capture (EDC), randomization (IRT), clinical trial management (CTMS), and clinical trial supply management, forecasting and optimization (CTSM).  BioClinica's Imaging and Cardiovascular division offers unmatched scientific expertise with its team of prominent medical researchers; electronic transfer, management, and independent review of medical images; plus cardiovascular safety monitoring including automated ECG, Thorough QT studies, Holter monitoring, ambulatory blood pressure monitoring and pulse wave analysis. With more than 29 years of experience and over 3000 successful trials to date, BioClinica has supported the development of many new treatments through all phases of the clinical trial process. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on three continents, and supports worldwide eClinical, comprehensive cardiovascular safety, and data management services from offices in the United States, Europe and Asia. For more information, please visit www.bioclinica.com.

SOURCE BioClinica, Inc.